What this history asks
Breast augmentation before silicone implants was not one technique waiting for a modern replacement. Between the early post-war years and 1961, surgeons tried several different ways to increase breast volume: moving a patient’s own tissue, injecting materials into the breast and placing solid or porous prostheses behind the breast. Each method addressed part of the same problem — how to create a stable, acceptable increase in volume — but each also exposed a different weakness in the biology of the breast and in the materials available at the time.
This article focuses on the materials and methods used around 1950–1961, the evidence that later historians use to describe them and the reasons they were abandoned or became obsolete. It is not a general operation guide. Historical case series, technical reports and later reviews used different patient groups, definitions and follow-up periods, so their results cannot be transferred directly to a contemporary cosmetic breast augmentation. The purpose is to understand why a contained implant became attractive, not to suggest that history by itself proves the safety or suitability of any modern device.
Why the problem was difficult
Breast volume is not an empty space that can be filled with any soft object. A result depends on the relationship between skin, glandular tissue, fat, the chest wall and the scar tissue that forms around a foreign material. The breast also moves, changes with age and weight, and has an important relationship with future examination and imaging. A material could look satisfactory immediately after surgery and still create a hard, distorted or painful breast months later.
Surgeons therefore faced several design questions at once. Should the added volume be living tissue or a separate prosthesis? If it was a prosthesis, should it be porous so that tissue could grow into it, or enclosed so that it could be removed? How could the material keep its shape without causing infection, erosion or a severe fibrous response? And how could a surgeon correct the result if the filler migrated or the prosthesis contracted? These questions explain why the pre-silicone period contains many apparently unrelated experiments.
Autologous tissue: flaps and dermal-fat grafts
One early direction used the patient’s own tissue. In a flap procedure, tissue containing skin, fat and sometimes its blood supply was moved from one part of the body to the breast area. In the 1950s, Longacre described local dermal-fat pedicle flaps for correction of the hypoplastic breast and for reconstructive situations. A pedicle was intended to preserve a connection to the donor region, which made the tissue different from a completely free piece of fat placed without a blood supply.
Autologous approaches had a biological attraction: the material was the patient’s own tissue rather than an industrial foreign body. They could also be shaped to address a local deficiency. However, a flap required additional dissection and created donor-site and blood-supply questions. The tissue could change in volume, scar or lose some of its intended shape. Historical reports also mixed cosmetic hypoplasia with reconstruction after mastectomy or correction of a defect, making direct comparison difficult.
It is important not to confuse these operations with modern structural fat grafting. Current fat-transfer techniques use different concepts for harvesting, processing and placing small parcels of fat, and contemporary studies assess them with modern imaging and follow-up. A dermal-fat flap reported in the 1950s is evidence about that historical operation, not evidence that all present-day fat-transfer protocols have the same risks or results.
Direct injections: volume without a defined pocket
Injection seemed simpler than constructing a flap. A surgeon could introduce a liquid, semi-liquid or emulsified substance directly into the breast and avoid a separate preformed prosthesis. Historical accounts describe attempts with paraffin, petroleum-based substances, vegetable oils, waxes, epoxy materials and other fillers. Glicenstein’s review describes the post-war period as one in which injected and autologous methods were tried but produced poor or sometimes disastrous results.
The central weakness of an injection was containment. A liquid did not necessarily remain where it was placed. It could spread through tissue planes, trigger inflammation and later form nodules, fibrosis or granulomatous reactions. Infection and skin problems could also develop. Once the substance had dispersed, removing it without removing affected tissue could be difficult. The resulting breast could become firm, irregular or painful, and the history of a previous injection could complicate later examination.
Liquid silicone illustrates why the word “silicone” needs careful historical qualification. Silicone oil was injected directly into breasts in the mid-twentieth century; this was not the same as a silicone-gel filler enclosed inside an elastomer shell. The 2022 review by Santanelli di Pompeo and colleagues places a report of liquid silicone injection in 1961, at the edge of the period covered here. The material, route and tissue response were fundamentally different from a contained silicone implant. Treating those two uses as interchangeable creates a misleading account of both the history and the later safety debate.
Porous sponge prostheses: the Ivalon experiment
The most influential non-silicone devices of the 1950s were sponge prostheses. Ivalon was a polyvinyl alcohol-formaldehyde sponge with an open, porous structure. Early work explored the material experimentally, and Pangman and Wallace began using it in women around 1951. The attraction was clear: the sponge was soft, could be carved into a breast shape and might allow vascularised tissue to grow into its surface. The idea was not simply to place a hard block behind the breast but to create a living interface between the material and the body.
Early impressions were encouraging, which helped the method spread. A 1955 report described the experience with the first 400 Ivalon breast prostheses, and the implant was sometimes described as a “living sponge” because tissue grew into its pores. Yet the same porous feature that seemed biologically helpful made the longer-term behaviour more complicated. Later accounts describe shrinkage and compression after roughly six to twelve months, accompanied by increasing firmness.
In retrospect, the important mechanism was not necessarily that the sponge itself melted away. The fibrous capsule around a foreign material could contract, compress the sponge and change the breast shape. A breast that had initially looked fuller could become hard, tight and less natural. The patient might experience discomfort, visible distortion or loss of volume. Attempts were made to modify Ivalon: the inner portion or the whole sponge could be wrapped in polyethylene, and double-layer constructions were tried. These changes altered the interface but did not reliably remove the underlying problem of capsular contraction.
Other sponges and preformed solid materials
Ivalon did not stand alone. Historical reviews describe a sequence of other sponge-like and solid materials used between roughly 1951 and the early 1960s. Etheron was a polyether sponge promoted for retromammary implantation. Polystan used polyethylene tape or fabric-like strips wound into a ball. Polyethylene sponges and polyethylene strips enclosed in a fabric or polymer casing were also evaluated. These devices differed in chemistry, shape and surface, but they were all attempts to solve the same engineering problem: provide a stable form without the disadvantages of a liquid injection.
The period literature was often optimistic about the immediate appearance of these materials. A surgeon could shape a sponge to create a particular contour, and the operation offered a more predictable starting volume than an injection. The weakness appeared with time. Peters’ historical review reports that many of these devices followed a similar pattern: after an initially acceptable result, the breast became very firm and lost a substantial amount of apparent volume within about a year. Later tissue contraction could collapse or deform a porous implant, while a solid or enclosed material could contribute to pressure, erosion, infection or difficult removal.
Contemporary reports also show how the aesthetic ideal influenced device choice. Some sponges were cut or moulded to produce a conical projection that reflected the fashion of the period. This is a useful reminder that “success” in a historical report included the shape surgeons and patients wanted at that time. It should not be read as evidence that a particular conical design, material or pocket would be preferred in a modern patient with different anatomy and expectations.
Why direct injection and porous devices failed for different reasons
It is tempting to group all pre-silicone methods together as failed implants, but their failure modes were not identical. Injection materials failed primarily because they could migrate, provoke a diffuse tissue response and become difficult to remove. They did not have a stable outer boundary that separated the filler from the breast. A contained device addressed that problem, but porous sponges created a different trade-off: tissue ingrowth and the foreign-body capsule could alter the shape and compress the prosthesis.
Both groups were also vulnerable to infection and skin breakdown. The breast is a mobile soft-tissue environment, and an implant that presses on thin tissue or becomes infected may erode toward the skin. Once a device is exposed, salvage becomes difficult. Historical papers did not always use the same language for infection, extrusion, erosion, contracture or discomfort, so a modern reader should be cautious about treating an old percentage as a directly comparable complication rate.
Follow-up was another limitation. A report might focus on the first postoperative months, while later reviews describe what happened after the implant had been in place for years. Patients who did well may not have returned for assessment, and patients with a problem may have been counted in a later revision series rather than the original study. These factors can make early enthusiasm look stronger than the complete long-term record.
What the 1950s taught implant designers
By the end of the 1950s, the limitations of a fully porous or freely injected approach were increasingly apparent. Surgeons wanted a device that could maintain a defined volume, remain reasonably soft, resist the body’s attempt to contract around it and be removed if necessary. That list of requirements points toward a contained implant: a shell separating the filler from surrounding tissue, with a shape and surface designed to manage the tissue interface.
The historical reviews by Glicenstein, Perry and Frame, and Santanelli di Pompeo and colleagues describe the early 1960s as the transition to silicone gel inside a silicone elastomer shell. That development did not make every later problem disappear. The first silicone devices were themselves associated with firmness, capsular contracture and design limitations, and implant technology continued to change. The significance of the pre-silicone period is therefore not that it ended with a perfect solution. It is that the period clarified the need for containment, controlled geometry and a more deliberate relationship between material and tissue.
In this sense, the history is a design story as much as a surgical story. A graft tried to make the breast larger with living tissue. An injection tried to add volume with minimal construction. A sponge tried to offer a shaped scaffold that the body might incorporate. Each approach solved one practical problem while creating another. The search for a contained implant emerged from those trade-offs rather than from a single moment of invention.
How to read this evidence today
The evidence base for 1950–1961 is mainly historical. It includes technical descriptions, case series, experimental work and later narrative reviews. It is valuable for identifying materials, dates and reported complications, but it does not meet the standards of a modern randomised comparison. Definitions of success, patient selection, surgical technique, anaesthesia, infection control and follow-up were not uniform. Some sources also report reconstruction and cosmetic augmentation together, even though the goals and tissue conditions can differ substantially.
For a present-day patient, the practical lesson is not to select a material from a historical list. It is to ask whether a current device has clear documentation, what its known complications are, how future changes will be assessed and what records will be supplied after surgery. The contemporary breast augmentation operation information explains the patient-planning context; this article supplies the historical background behind the contained-implant concept. A coordinated breast augmentation package page may help explain logistics, but it is not evidence of historical or clinical superiority.
Readers who want the practical questions patients ask about assessment, consent and follow-up can also read the breast augmentation safety and recovery guide. The two pages have different purposes: the practical guide discusses a contemporary care pathway, while this academic article explains why earlier materials and methods were abandoned. For the next stage of the evidence library, the breast augmentation research hub will collect related studies on implant development and technique as separately reviewed articles become available.
Conclusion
Before silicone gel was placed inside a purpose-built shell, breast augmentation moved through a long period of experimentation. Dermal-fat flaps used the patient’s own tissue but required complex reshaping and could change over time. Injections were simple in concept but lacked containment and could cause diffuse, difficult-to-treat tissue reactions. Ivalon, Etheron, Polystan and polyethylene-based sponges offered a shaped prosthesis, yet tissue ingrowth and capsular contraction could produce firmness, shrinkage, distortion, erosion or discomfort.
Those failures created a clear demand for a contained implant, but they did not prove that the next generation would be risk-free. The most reliable historical conclusion is narrower: long-term breast augmentation requires more than immediate volume. It requires a material, shell, shape, tissue interface and follow-up plan that can be assessed over time. That principle remains relevant whenever a patient and surgeon discuss a modern implant.